Literature DB >> 300182

Total T lymphocytes in primary bronchial carcinoma.

H L Roberts, W T Donohoe, S Hewitt, D A Price Evans.   

Abstract

Percentage and absolute levels of circulating T lymphocytes were measured in 48 patients with bronchial carcinoma. These were compared with control values from nine healthy adults and 19 age-matched patients with benign disorders. A further 20 patients who had been given postoperative immunotherapy after complete resection of bronchial carcinoma were also studied. There was no significant difference in the mean percentage T cells between the groups. Lymphopenia, however, was a feature of the bronchial cancer patients with metastatic disease. This resulted in a significant diminution of absolute T cells in this group. There is no evidence, with the technique employed in this study, of a total T-cell deficiency in early bronchial carcinoma.

Entities:  

Mesh:

Year:  1977        PMID: 300182      PMCID: PMC470530          DOI: 10.1136/thx.32.1.84

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Editorial: T-rosette forming cells, cellular immunity and cancer.

Authors:  H H Fudenberg; J Wybran; D Robbins
Journal:  N Engl J Med       Date:  1975-02-27       Impact factor: 91.245

2.  E and EAC rosetting lymphocytes in patients with carcinoma of bronchus I. Some parameters of the test and of its prognostic significance.

Authors:  H M Anthony; J A Kirk; K E Madsen; M K Mason; G H Templeman
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

3.  Thymus-dependent lymphocyte levels in bronchogenic carcinoma: correlations with histology, clinical stage, and clinical course after surgical treatment.

Authors:  A L Dellon; C Potvin; P B Chretien
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

4.  Effect of radiation therapy for urologic cancer on circulating thymus-derived lymphocytes.

Authors:  W J Catalona; C Potvin; P B Chretien
Journal:  J Urol       Date:  1974-08       Impact factor: 7.450

5.  Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.

Authors:  A Brugarolas; T Han; H Takita; J Minowada
Journal:  N Y State J Med       Date:  1973-03-15

Review 6.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

7.  Immunologic alterations in bronchogenic cancer. Sequential study.

Authors:  M J Krant; G Manskopf; C S Brandrup; M A Madoff
Journal:  Cancer       Date:  1968-04       Impact factor: 6.860

8.  T-cell deficiency in patients with squamous cell cancer of the head and neck.

Authors:  H J Wanebo; M Y Jun; E W Strong; H Oettgen
Journal:  Am J Surg       Date:  1975-10       Impact factor: 2.565

9.  T and B lymphocytes in breast cancer stage relationship and abrogation of T-lymphocyte depression by enzyme treatment in vitro.

Authors:  R H Whitehead; J Thatcher; C Teasdale; G P Roberts; L E Hughes
Journal:  Lancet       Date:  1976-02-14       Impact factor: 79.321

10.  Quantitation of T- and B-lymphocytes in peripheral blood of patients with solid tumours. I. Relation to other parameters of in vivo and in vitro immune competence.

Authors:  J Harris; T Stewart; D P Sengar; D Hyslop
Journal:  Can Med Assoc J       Date:  1975-04-19       Impact factor: 8.262

View more
  1 in total

1.  Changes of peripheral T lymphocyte subsets following treatment in patients with bronchogenic carcinoma.

Authors:  J O Kim; S Y Kim
Journal:  Korean J Intern Med       Date:  1989-07       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.